Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Change in Inventory (2017 - 2025)

Inspire Medical Systems (INSP) has disclosed Change in Inventory for 9 consecutive years, with $3.5 million as the latest value for Q4 2025.

  • Quarterly Change in Inventory fell 72.28% to $3.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $65.2 million through Dec 2025, up 40.97% year-over-year, with the annual reading at $65.2 million for FY2025, 40.97% up from the prior year.
  • Change in Inventory hit $3.5 million in Q4 2025 for Inspire Medical Systems, down from $20.1 million in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $21.9 million in Q2 2025 to a low of -$6.7 million in Q3 2022.
  • Historically, Change in Inventory has averaged $6.8 million across 5 years, with a median of $5.1 million in 2022.
  • Biggest five-year swings in Change in Inventory: plummeted 394.47% in 2022 and later skyrocketed 1613.74% in 2023.
  • Year by year, Change in Inventory stood at $1.7 million in 2021, then tumbled by 296.68% to -$3.3 million in 2022, then skyrocketed by 338.45% to $7.8 million in 2023, then surged by 63.25% to $12.7 million in 2024, then crashed by 72.28% to $3.5 million in 2025.
  • Business Quant data shows Change in Inventory for INSP at $3.5 million in Q4 2025, $20.1 million in Q3 2025, and $21.9 million in Q2 2025.